Inmune Bio, Inc. Uncategorized Contracts & Agreements
20 Contracts & Agreements
- Form of Nonqualified Option Agreement of INmune Bio Inc (Filed With SEC on May 16, 2024)
- Amendment No. 3 to Rights Agreement, dated as of December 14, 2023, between the Company and VStock Transfer LLC, as Rights Agent (Filed With SEC on December 18, 2023)
- AMENDED AND RESTATED INMUNE BIO, INC. 2021 STOCK INCENTIVE PLAN (Filed With SEC on June 1, 2023)
- Amendment No. 2 to Rights Agreement, dated as of December 9, 2022, between the Company and VStock Transfer LLC, as Rights Agent (Filed With SEC on December 12, 2022)
- Form of Option Agreement for Employees of the Company (Filed With SEC on March 24, 2022)
- Form of Option Agreement between the Company and Non-Employee Directors and consultants (Filed With SEC on March 24, 2022)
- Description of Securities of INmune Bio, Inc (Filed With SEC on March 3, 2022)
- Amendment No. 1 to Rights Agreement, dated as of December 20, 2021, between INmune Bio Inc. and Vstock Transfer, LLC (Filed With SEC on December 21, 2021)
- Form of Option Agreement for Employees of the Company (Filed With SEC on June 24, 2021)
- Form of Option Agreement between the Company and Non-Employee Directors (Filed With SEC on June 24, 2021)
- Option Cancellation Agreement between INmune Bio Inc. and Xencor, Inc (Filed With SEC on June 15, 2021)
- Form of agreement between INmune Bio Inc. and National Securities Corporation, dated March 29, 2021 (Filed With SEC on March 29, 2021)
- Rights Agreement, dated as of December 30, 2020, by and between INmune Bio Inc. and VStock Transfer, LLC (Filed With SEC on January 4, 2021)
- Rights Agreement, dated as of December 30, 2020, by and between INmune Bio Inc. and VStock Transfer, LLC (Filed With SEC on December 30, 2020)
- Award Agreement dated as of February 4, 2020 (Filed With SEC on February 10, 2020)
- Award Letter dated as of February 22, 2019 from the Alzheimers Association to INmune Bio, Inc (Filed With SEC on February 28, 2019)
- Form of Placement Agent Agreement (Filed With SEC on November 20, 2018)
- Form of Lock-up Agreement (Filed With SEC on October 29, 2018)
- Form of Placement Agent Agreement (Filed With SEC on September 26, 2018)
- Amendment to the Consultancy Agreement between INMune Bio Inc. and Mark Lowdell (Filed With SEC on August 30, 2018)
